Bausch Health
BHC · NYSE
Bulios Fair Price
$7.15
26.9% upside
Current Price
$5.64
According to Bulios Fair Price, BHC is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Bausch Health Companies Inc. is a Canadian pharmaceutical company focused on the development and manufacturing of medicines and healthcare products. Originally founded in 1959 as Valeant Pharmaceuticals, the company rebranded as Bausch Health in 2018, shifting its focus to products in ophthalmology, dermatology, dental care, and cardiovascular medicine. Bausch Health specializes in prescription drugs, over-the-counter products, and innovative medical devices, and is known for its strong portfolio in ophthalmology and medical technologies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Thomas J. Appio
Employees
20,300
Headquarters
Laval
Upcoming events
Earnings
Upcoming earnings report